Literature DB >> 6637994

Prevalence of diabetes and impaired glucose tolerance in the biracial (Melanesian and Indian) population of Fiji: a rural-urban comparison.

P Zimmet, R Taylor, P Ram, H King, G Sloman, L R Raper, D Hunt.   

Abstract

Rural-urban and ethnic comparisons of impaired glucose tolerance and diabetes mellitus were made in the biracial population of Fiji in 1980. No statistically significant differences existed in age-standardized impaired glucose tolerance prevalence between rural and urban groups or between Melanesians and Indians. The age-standardized prevalence of diabetes in the rural Melanesian male population was one-third that of the urban male population (1.1 vs. 3.5%). In females, there was a sixfold rural-urban difference (1.2 vs. 7.1%). By contrast, rural and urban Indians had similar rates (12.1 vs. 12.9% for males; 11.3 vs. 11.0% for females). Standardization of two-hour plasma glucose for age and obesity did not eliminate the rural-urban difference in plasma glucose concentration for Melanesian males and females. The results in Melanesians confirm previously reported rural-urban diabetes prevalence differences, and suggest that factors other than obesity, such as differences in physical activity, diet, stress, or other, as yet undetermined, factors contribute to this difference. The absence of a rural-urban difference in diabetes prevalence in Indians may suggest that genetic factors are more important for producing diabetes in this ethnic group, or that causative environmental factors such as diet operate similarly upon both the rural and the urban populations.

Entities:  

Mesh:

Year:  1983        PMID: 6637994     DOI: 10.1093/oxfordjournals.aje.a113678

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  32 in total

Review 1.  The genetics of type 2 diabetes.

Authors:  M McCarthy; S Menzel
Journal:  Br J Clin Pharmacol       Date:  2001-03       Impact factor: 4.335

Review 2.  Impaired glucose tolerance.

Authors:  J S Yudkin; K G Alberti; D G McLarty; A B Swai
Journal:  BMJ       Date:  1990-09-01

3.  Smoking rates in Pacific islands.

Authors:  J Tuomilehto; P Zimmet; R Taylor; P Bennet; E Wolf; J Kankaanpää
Journal:  Bull World Health Organ       Date:  1986       Impact factor: 9.408

Review 4.  Epidemiology of type II diabetes: an international perspective.

Authors:  T J Songer; P Z Zimmet
Journal:  Pharmacoeconomics       Date:  1995       Impact factor: 4.981

5.  Cardiovascular diseases in Chinese, Malays, and Indians in Singapore. II. Differences in risk factor levels.

Authors:  K Hughes; P P Yeo; K C Lun; A C Thai; S P Sothy; K W Wang; J S Cheah; W O Phoon; P Lim
Journal:  J Epidemiol Community Health       Date:  1990-03       Impact factor: 3.710

Review 6.  Diabetes in the tropics: differences from diabetes in the West.

Authors:  V Mohan; J M Ekoe; A Ramachandran; C Snehalatha; M Viswanathan
Journal:  Acta Diabetol Lat       Date:  1986 Apr-Jun

7.  Prevalences of diabetes and cardiovascular disease risk factors in Hindu Indian subcommunities in Tanzania.

Authors:  K L Ramaiya; A B Swai; D G McLarty; R S Bhopal; K G Alberti
Journal:  BMJ       Date:  1991-08-03

8.  Oral glucose tolerance and ambient temperature in non-diabetic subjects.

Authors:  A O Akanji; M Bruce; K Frayn; T D Hockaday; G M Kaddaha
Journal:  Diabetologia       Date:  1987-06       Impact factor: 10.122

9.  Increased nicotinamide nucleotide transhydrogenase levels predispose to insulin hypersecretion in a mouse strain susceptible to diabetes.

Authors:  K Aston-Mourney; N Wong; M Kebede; S Zraika; L Balmer; J M McMahon; B C Fam; J Favaloro; J Proietto; G Morahan; S Andrikopoulos
Journal:  Diabetologia       Date:  2007-10-06       Impact factor: 10.122

10.  Prospective surveillance of invasive group a streptococcal disease, Fiji, 2005-2007.

Authors:  Andrew C Steer; Adam Jenney; Joseph Kado; Michael F Good; Michael Batzloff; Lepani Waqatakirewa; E Kim Mullholland; Jonathan R Carapetis
Journal:  Emerg Infect Dis       Date:  2009-02       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.